Cite
Rao PS, Moore CC, Mbonde AA, et al. Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics (Basel). 2021;10(6)doi: 10.3390/antibiotics10060739.
Rao, P. S., Moore, C. C., Mbonde, A. A., Nuwagira, E., Orikiriza, P., Nyehangane, D., Al-Shaer, M. H., Peloquin, C. A., Gratz, J., Pholwat, S., Arinaitwe, R., Boum, Y., Mwanga-Amumpaire, J., Houpt, E. R., Kagan, L., Heysell, S. K., & Muzoora, C. (2021). Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics (Basel, Switzerland), 10(6), . https://doi.org/10.3390/antibiotics10060739
Rao, Prakruti S, et al. "Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness." Antibiotics (Basel, Switzerland) vol. 10,6 (2021). doi: https://doi.org/10.3390/antibiotics10060739
Rao PS, Moore CC, Mbonde AA, Nuwagira E, Orikiriza P, Nyehangane D, Al-Shaer MH, Peloquin CA, Gratz J, Pholwat S, Arinaitwe R, Boum Y, Mwanga-Amumpaire J, Houpt ER, Kagan L, Heysell SK, Muzoora C. Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics (Basel). 2021 Jun 18;10(6). doi: 10.3390/antibiotics10060739. PMID: 34207312; PMCID: PMC8235594.
Copy
Download .nbib